Evidence map›Paper›PMID 42550806›Full record

ArticlePLoS biology2026

let-7 miRNA and lin-46 mRNA are essential targets of the LIN28 RNA-binding protein in Caenorhabditis elegans developmental timing regulation.

Jana Brunner, Anca Neagu, Dimos Gaidatzis, Lucas J Morales Moya, Helge Großhans

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jana BrunnerFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Anca NeaguFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Dimos GaidatzisFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Lucas J Morales MoyaFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Helge GroßhansFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.ORCID https://orcid.org/0000-0002-8169-6905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The RNA-binding protein (RBP) LIN28 is a key regulator of temporal cell fates, promoting stem cell identity and suppressing differentiation. It regulates the processing of the let-7 miRNA but additionally binds thousands of mRNAs, suggesting a model of coordinated regulation across many targets. Yet, direct evidence for such a network function is scarce for both LIN28 and other broadly binding RBPs. Here, we show that in Caenorhabditis elegans larvae, loss of LIN28 leaves the levels of most LIN28-bound transcripts unchanged. The only exceptions are the lin-46 mRNA and the let-7 miRNA. Comprehensive genetic analyses identify these two as the functionally essential LIN28 targets: lin-28; lin-46; let-7 triple mutant animals exhibit complete suppression of the lin-28(0) precocious heterochronic phenotypes and recapitulate the retarded lin-46; let-7 double mutant phenotypes. Conversely, simultaneous overexpression of lin-46 and let-7 mimics LIN28 loss. Unexpectedly, LIN28 controls not only cell identity but also the tempo of development, using the same two targets. These findings establish a close functional link between the heterochronic pathway and the clock regulating developmental tempo and demonstrate that an RBP can achieve complex biological outcomes through a small set of targets.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsGene Expression Regulation, DevelopmentalMicroRNAsRNA-Binding ProteinsRNA, MessengerAnimalsMutationRepressor ProteinsCaenorhabditis elegans Proteinslet-7 microRNA, C elegansLIN-28 protein, C elegansMicroRNAsRepressor ProteinsRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID42550806
PMCPMC13436749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.